Erbitux Plus Chemo Improves Lung Cancer
Outcomes
SATURDAY, May 31 (HealthDay News) -- The long-awaited results of
a trial of the biologic drug Erbitux on patients with advanced
non-small cell lung cancer show it prolonged survival by about five
weeks when combined with chemotherapy.
New Hope for Tough-to-Treat Cancers
SATURDAY, May 31 (HealthDay News) -- Patients diagnosed with
pancreatic cancer -- which historically carries a grim prognosis --
nearly doubled their overall survival when the cancer drug Gemzar
was used after surgery, new research shows.